Paroxetine vs pregabalin for the management of neuropathic pain in multiple sclerosis

doi:10.5313/wja.v3.i2.181

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 2

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (12342)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-5) series.

Item

Count

PDF

449

WORD

374

HTML

8090

Figures (1-3)

356

Tables (1-5)

293

Sum=9562

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1383

Download

1397

Sum=2780

Jul 27, 2014 (publication date) through Jan 8, 2025

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Anesthesiology

ISSN

2218-6182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Anesthesiol. Jul 27, 2014; 3(2): 181-188
Published online Jul 27, 2014. doi: 10.5313/wja.v3.i2.181

Full Size Figure Download Figure

Figure 3 Attrition by study group. Attrition rates (shown in the format of survival distribution by study day) for each group (paroxetine and pregabalin) are presented. The average study duration (days) for paroxetine = 27.3 and for pregabalin = 49.5.

Citation: Turcotte DA, Doupe M, Torabi M, Gomori AJ, Ethans K, Esfahani F, Galloway K, Namaka MP. Paroxetine vs pregabalin for the management of neuropathic pain in multiple sclerosis. World J Anesthesiol 2014; 3(2): 181-188
URL: https://www.wjgnet.com/2218-6182/full/v3/i2/181.htm
DOI: https://dx.doi.org/10.5313/wja.v3.i2.181